$VICR

Schmidt James F sold $158K of VICR

Schmidt James F (CFO, Treasurer, Secretary) sold 500 shares of VICOR CORP (VICR) at $316.33 ($0.16M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Schmidt James F
Published Jun 2, 2026, 5:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 5:05 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The market may briefly react to insider activity, but the 10b5-1 structure generally limits inference about near-term fundamentals.

02

Market read

A single insider sale datapoint with reduced interpretability due to 10b5-1; likely limited trading impact absent other catalysts.

03

What to watch

The filing does not indicate whether other insiders bought/sold, nor does it quantify whether the sale was routine vs. unusually large relative to prior patterns.

Relevance 6/10Novelty 6/10Timing: Filed 2026-06-02; reflects sale executed 2026-06-01.

Background

This is an SEC Form 4 insider transaction disclosure for Vicor Corp, reporting an open-market sale by a senior officer under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

VICR disclosed an officer/director open-market sale: CFO/Treasurer/Secretary James F. Schmidt sold 500 shares at $316.33 on 2026-06-01 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any impact is likely brief and sentiment-driven.

Evidence & confidence

The filing provides a specific transaction datapoint (size, price, post-sale holdings) but no accompanying fundamental catalyst; 10b5-1 reduces interpretability as a new bearish signal.

Market effects

Minimal—this is company-specific insider transaction with no stated operational/sector catalyst.

None expected beyond VICR-specific sentiment.

None expected.

Counterpoint

Even with 10b5-1, repeated or sizable insider sales can coincide with internal expectations of limited near-term upside, potentially pressuring sentiment.

Key entities

  • VICOR CORP

    Subject of the Form 4 insider transaction disclosure.

  • Schmidt James F

    CFO, Treasurer, Secretary; sold 500 shares on 2026-06-01 under a 10b5-1 plan.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: